• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞与细胞因子诱导的杀伤细胞之间的相互作用导致这两种细胞群体均被激活。

Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.

作者信息

Märten A, Ziske C, Schöttker B, Renoth S, Weineck S, Buttgereit P, Schakowski F, von Rücker A, Sauerbruch T, Schmidt-Wolf I G

机构信息

Medizinische Klinik und Poliklinik I, Allgemeine Innere Medizin, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.

出版信息

J Immunother. 2001 Nov-Dec;24(6):502-10. doi: 10.1097/00002371-200111000-00007.

DOI:10.1097/00002371-200111000-00007
PMID:11759073
Abstract

Dendritic cells (DCs) are major antigen-presenting cells. They are capable of capturing and processing tumor antigens, expressing lymphocyte costimulatory molecules, and secreting cytokines to initiate immune responses. Here, the authors tested the effect of cytokine-induced killer (CIK) cells, a population that includes CD3+CD56+ cells (natural killer T cells), with regard to their capacity to immunomodulate DCs. Cytokine-induced killer cells were cocultured with autologous DCs generated from peripheral blood mononuclear cells. Expression of markers typical for both populations was measured using flow cytometry, and secretion of interleukin (IL)-12 was determined using enzyme-linked immunosorbent assays. Cytotoxicity assays were performed to investigate the role of IL-12 and the importance of cell-cell interactions. Considering this, receptors for IL-12 and CD40 were blocked and cocultures were performed with cell culture inserts. Coculture of CIK cells led to a significant increase of DC-specific, costimulatory, and antigen-presenting molecules in DC cultures. In addition, coculture resulted in a dramatically increase of IL-12 secretion by DCs and to a significant increase in cytotoxic activity of CIK cells toward carcinoma cells. Blockage of IL-12 uptake decreased the cytolytic activity of CIK cells. Cytokine secretion was shown to be important for activation of CIK cells, and also cellular interactions between DCs and effector cells caused a higher cytolytic capacity. Interactions between DCs and CIK cells caused changes in the surface molecule expression of both populations, led to an increase of IL-12 secretion, and rendered an improved cytotoxic activity. The natural killer T cell subpopulation seems to be responsible for this effect. Therefore, coculture of DCs with CIK cells may have a major impact on immunotherapeutic protocols for patients with cancer.

摘要

树突状细胞(DCs)是主要的抗原呈递细胞。它们能够捕获和处理肿瘤抗原,表达淋巴细胞共刺激分子,并分泌细胞因子以启动免疫反应。在此,作者测试了细胞因子诱导的杀伤细胞(CIK),即包括CD3 + CD56 +细胞(自然杀伤T细胞)的群体,对其免疫调节DCs能力的影响。将细胞因子诱导的杀伤细胞与从外周血单核细胞产生的自体DCs共培养。使用流式细胞术测量两个群体典型标志物的表达,并使用酶联免疫吸附测定法测定白细胞介素(IL)-12的分泌。进行细胞毒性测定以研究IL-12的作用和细胞间相互作用的重要性。考虑到这一点,阻断IL-12和CD40的受体,并使用细胞培养插入物进行共培养。CIK细胞的共培养导致DC培养物中DC特异性、共刺激和抗原呈递分子的显著增加。此外,共培养导致DCs分泌IL-12显著增加,并导致CIK细胞对癌细胞的细胞毒性活性显著增加。阻断IL-12摄取降低了CIK细胞的溶细胞活性。已表明细胞因子分泌对CIK细胞的激活很重要,并且DCs与效应细胞之间的细胞相互作用也导致更高的溶细胞能力。DCs与CIK细胞之间的相互作用导致两个群体的表面分子表达发生变化,导致IL-12分泌增加,并提高了细胞毒性活性。自然杀伤T细胞亚群似乎负责这种效应。因此,DCs与CIK细胞的共培养可能对癌症患者的免疫治疗方案产生重大影响。

相似文献

1
Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.树突状细胞与细胞因子诱导的杀伤细胞之间的相互作用导致这两种细胞群体均被激活。
J Immunother. 2001 Nov-Dec;24(6):502-10. doi: 10.1097/00002371-200111000-00007.
2
Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.与细胞因子诱导的杀伤细胞共培养的细胞毒性树突状细胞的生物学活性及其对急性白血病细胞的影响。
Genet Mol Res. 2015 Oct 27;14(4):13208-14. doi: 10.4238/2015.October.26.17.
3
[Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].共培养树突状细胞和细胞因子诱导的杀伤细胞对肺癌的体内外抗肿瘤作用
Ai Zheng. 2006 Nov;25(11):1329-33.
4
Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells.经干扰素-α或CpG基序处理的共培养树突状细胞后效应细胞的抗肿瘤能力。
Arch Immunol Ther Exp (Warsz). 2006 Nov-Dec;54(6):403-9. doi: 10.1007/s00005-006-0048-5. Epub 2006 Nov 21.
5
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.用编码甲胎蛋白的腺病毒转导并与自体细胞因子诱导淋巴细胞共培养的患者来源树突状细胞,可诱导针对肝癌细胞的特异性强免疫反应。
Liver Int. 2006 Apr;26(3):369-79. doi: 10.1111/j.1478-3231.2005.01235.x.
6
[Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].树突状细胞与细胞因子诱导的杀伤细胞共培养导致细胞因子诱导的杀伤细胞在体外和体内对肿瘤细胞的细胞毒性活性显著增加。
Zhonghua Xue Ye Xue Za Zhi. 2004 May;25(5):277-80.
7
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.自体细胞因子诱导杀伤细胞(CIK)、树突状细胞-CIK(DC-CIK)和半同种异体DC-CIK抗肿瘤免疫反应的比较研究
Chin J Cancer. 2010 Jul;29(7):641-8. doi: 10.5732/cjc.009.10772.
8
[Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].[树突状细胞减少细胞因子诱导的杀伤细胞中CD4 + CD25 +细胞的数量和功能]
Zhonghua Yi Xue Za Zhi. 2005 Nov 23;85(44):3134-8.
9
[Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].[共培养的细胞因子诱导杀伤细胞和树突状细胞对多药耐药肿瘤细胞系的杀伤活性]
Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):733-7.
10
[The proliferation profile in vitro and anti-tumor effects of dendritic cells co-culturing with CIK cells].树突状细胞与细胞因子诱导的杀伤细胞共培养的体外增殖特性及抗肿瘤作用
Shi Yan Sheng Wu Xue Bao. 2003 Oct;36(5):375-80.

引用本文的文献

1
Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions.晚期透明细胞肾细胞癌免疫治疗和靶向治疗的进展:当前策略与未来方向
Front Immunol. 2025 Jul 3;16:1582887. doi: 10.3389/fimmu.2025.1582887. eCollection 2025.
2
The Emerging Mechanisms and Therapeutic Potentials of Dendritic Cells in NSCLC.非小细胞肺癌中树突状细胞的新兴机制及治疗潜力
J Inflamm Res. 2025 Apr 14;18:5061-5076. doi: 10.2147/JIR.S506644. eCollection 2025.
3
Current status of cytokine-induced killer cells and combination regimens in breast cancer.
细胞因子诱导的杀伤细胞及联合方案在乳腺癌中的研究现状
Front Immunol. 2025 Feb 6;16:1476644. doi: 10.3389/fimmu.2025.1476644. eCollection 2025.
4
Cytokine-Induced Killer Cells: A Unique Platform for Adoptive Cell Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation.细胞因子诱导的杀伤细胞:异基因造血干细胞移植后过继性细胞免疫治疗的独特平台。
Transfus Med Hemother. 2024 Sep 24;52(1):77-95. doi: 10.1159/000540964. eCollection 2025 Feb.
5
Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials.树突状细胞与细胞因子诱导的杀伤细胞联合免疫疗法治疗实体瘤:一项随机对照试验的系统评价与荟萃分析
J Transl Med. 2024 Dec 20;22(1):1122. doi: 10.1186/s12967-024-05940-y.
6
Cytokine-induced killer cells: new insights for therapy of hematologic malignancies.细胞因子诱导的杀伤细胞:恶性血液病治疗的新见解。
Stem Cell Res Ther. 2024 Aug 13;15(1):254. doi: 10.1186/s13287-024-03869-z.
7
Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy.肾细胞癌的当前治疗选择:聚焦于细胞免疫疗法。
Cancers (Basel). 2024 Mar 19;16(6):1209. doi: 10.3390/cancers16061209.
8
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer.免疫细胞疗法治疗癌症的进展与前景
Cell Transplant. 2024 Jan-Dec;33:9636897241231892. doi: 10.1177/09636897241231892.
9
Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible.自体 CIK 细胞联合化疗作为局部晚期或转移性胃癌的一线治疗是安全可行的。
Front Immunol. 2023 Nov 1;14:1267369. doi: 10.3389/fimmu.2023.1267369. eCollection 2023.
10
How can Cytokine-induced killer cells overcome CAR-T cell limits.细胞因子诱导的杀伤细胞如何克服 CAR-T 细胞的局限性。
Front Immunol. 2023 Aug 22;14:1229540. doi: 10.3389/fimmu.2023.1229540. eCollection 2023.